Leuko

Boston, United States

Leuko Labs develops non-invasive white blood cell monitoring device.

Jul 2024

Grant

Top Investors

Good Growth CapitalPegasus Tech VenturesNina CapitalIAG Capital PartnersMassVentures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Leuko's investors?

Leuko's investors include Good Growth Capital, Pegasus Tech Ventures, Nina Capital, IAG Capital Partners, MassVentures.

Where is Leuko headquartered?

Leuko is headquartered in Boston, United States.

What does Leuko do?

Leuko Labs develops non-invasive white blood cell monitoring device.

What stage is Leuko at?

Leuko is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 23, 2024.

MLA

"Leuko — Funding & Investors." VCBacked, July 23, 2024, https://www.vcbacked.co/company/leuko. Accessed July 1, 2026.

APA

VCBacked. (2024). Leuko — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/leuko

Wikipedia (cite web)

{{cite web |title=Leuko — Funding & Investors |url=https://www.vcbacked.co/company/leuko |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 23, 2024.